Increase/Decrease in Cash: The total change in cash for the company over the given period.
Amicus Therapeutics, Inc. (FOLD) had Increase/Decrease in Cash of $-54.70M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$154.69M |
|
$-24.42M |
|
$15.22M |
|
$139.47M |
|
$164.16M |
|
$-9.47M |
|
$-9.71M |
|
$-19.18M |
|
$-19.18M |
|
$-24.42M |
|
$-24.42M |
|
$-24.42M |
|
$-24.42M |
|
$-9.47M |
|
$-6.99M |
|
308.25M |
|
308.25M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$538.01M |
|
$28.57M |
|
$277.30M |
|
$815.30M |
|
$167.65M |
|
$391.32M |
|
$443.35M |
|
$611.00M |
|
$204.30M |
|
$-9.06M |
|
$204.30M |
|
308.06M |
|
| Cash Flow Statement Financials | |
$-18.77M |
|
$-38.64M |
|
$-12.10M |
|
$216.72M |
|
$162.01M |
|
|
Increase/Decrease in Cash |
$-54.70M |
$42.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.21 |
|
-- |
|
-- |
|
0.66 |
|
1.92 |
|
90.16% |
|
-6.12% |
|
-6.12% |
|
-- |
|
-12.40% |
|
-15.79% |
|
$-21.38M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.10 |
|
1.46 |
|
61.58 |
|
-11.95% |
|
269.45% |
|
-3.00% |
|
-4.10% |
|
$0.66 |
|
$-0.07 |
|
$-0.06 |
|